$GATO
Gatos Silver, Inc.

2023 Q2 Form 10-K Financial Statement

#000110465923074920 Filed on June 27, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2022 Q4 2022
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $6.130M $8.500M $25.47M
YoY Change 43.9% 130.35% 18.74%
% of Gross Profit
Research & Development $0.00 $0.00 $110.0K
YoY Change -100.0% -93.37%
% of Gross Profit
Depreciation & Amortization $30.00K $50.00K $180.0K
YoY Change -40.0% 25.0% 100.0%
% of Gross Profit
Operating Expenses $6.160M $8.550M $25.76M
YoY Change 43.26% 114.29% 11.08%
Operating Profit
YoY Change
Interest Expense $1.290M $12.62M $44.80M
YoY Change -85.07% -36.99% 5.11%
% of Operating Profit
Other Income/Expense, Net $1.094M $1.620M $4.955M
YoY Change -1.44% 1.89% -204.58%
Pretax Income -$3.593M -$2.210M $16.09M
YoY Change -164.49% -96.48% -137.05%
Income Tax $0.00 $1.570M $1.565M
% Of Pretax Income 9.72%
Net Earnings -$3.593M -$3.770M $14.53M
YoY Change 48.1% -93.99% -133.45%
Net Earnings / Revenue
Basic Earnings Per Share -$0.05 $0.21
Diluted Earnings Per Share -$0.05 -$0.05 $0.21
COMMON SHARES
Basic Shares Outstanding 69.16M 69.16M
Diluted Shares Outstanding 69.16M 69.31M

Balance Sheet

Concept 2023 Q2 2022 Q4 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $9.100M $17.00M $17.00M
YoY Change 24.66% 157.58% 157.58%
Cash & Equivalents $9.139M $17.00M $17.00M
Short-Term Investments
Other Short-Term Assets $15.68M $16.87M $3.100M
YoY Change 605.58% 374.17% 3.33%
Inventory
Prepaid Expenses $1.633M $2.890M
Receivables
Other Receivables
Total Short-Term Assets $26.98M $35.65M $35.60M
YoY Change 167.78% 202.97% 201.69%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $354.3M $347.8M $347.8M
YoY Change 3.42% 4.32% 4.32%
Other Assets $44.00K $60.00K $100.0K
YoY Change -8.33% 71.43%
Total Long-Term Assets $354.3M $347.9M $347.9M
YoY Change -5.43% -2.11% 4.35%
TOTAL ASSETS
Total Short-Term Assets $26.98M $35.65M $35.60M
Total Long-Term Assets $354.3M $347.9M $347.9M
Total Assets $381.3M $383.5M $383.5M
YoY Change -0.9% 4.46% 11.1%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $484.0K $586.0K $600.0K
YoY Change 144.44% 198.98% -57.14%
Accrued Expenses $2.749M $2.761M $4.700M
YoY Change 344.82% 343.18%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $25.70M $26.40M $26.40M
YoY Change 1876.92% 1785.71% 1785.71%
LONG-TERM LIABILITIES
Long-Term Debt $8.700M $8.700M $8.700M
YoY Change -31.5% -30.95% -30.95%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $8.700M $8.700M $8.700M
YoY Change -31.5% -30.95% -30.95%
TOTAL LIABILITIES
Total Short-Term Liabilities $25.70M $26.40M $26.40M
Total Long-Term Liabilities $8.700M $8.700M $8.700M
Total Liabilities $34.40M $35.00M $35.00M
YoY Change 145.71% 150.0% 150.0%
SHAREHOLDERS EQUITY
Retained Earnings -$201.5M -$198.7M
YoY Change 15.5% 4.13%
Common Stock $117.0K $117.0K
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $346.9M $348.5M $348.5M
YoY Change
Total Liabilities & Shareholders Equity $381.3M $383.5M $383.5M
YoY Change -0.9% 4.46% 11.1%

Cashflow Statement

Concept 2023 Q2 2022 Q4 2022
OPERATING ACTIVITIES
Net Income -$3.593M -$3.770M $14.53M
YoY Change 48.1% -93.99% -133.45%
Depreciation, Depletion And Amortization $30.00K $50.00K $180.0K
YoY Change -40.0% 25.0% 100.0%
Cash From Operating Activities -$3.770M $5.870M $14.55M
YoY Change -286.63% -197.83% -167.74%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $30.00K $60.00K
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change -100.0%
Cash From Investing Activities $0.00 -$30.00K -$60.00K
YoY Change -100.0% -99.98%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 -4.110M -4.106M
YoY Change -2155.0% -102.95%
NET CHANGE
Cash From Operating Activities -3.770M 5.870M 14.55M
Cash From Investing Activities 0.000 -30.00K -60.00K
Cash From Financing Activities 0.000 -4.110M -4.106M
Net Change In Cash -3.770M 1.730M 10.39M
YoY Change -289.45% -129.83% -107.24%
FREE CASH FLOW
Cash From Operating Activities -$3.770M $5.870M $14.55M
Capital Expenditures $0.00 $30.00K $60.00K
Free Cash Flow -$3.770M $5.840M $14.49M
YoY Change -289.45%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001517006
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
001-39649
CY2022 dei Entity Registrant Name
EntityRegistrantName
GATOS SILVER, INC.
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
27-2654848
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
925 W Georgia Street, Suite 910
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Vancouver
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
BC
CY2022 dei Entity Address Country
EntityAddressCountry
CA
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
V6C 3L2
CY2022 dei City Area Code
CityAreaCode
604
CY2022 dei Local Phone Number
LocalPhoneNumber
424-0984
CY2022 dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
CY2022 dei Trading Symbol
TradingSymbol
GATO
CY2022 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2022 dei Entity Ex Transition Period
EntityExTransitionPeriod
true
CY2022 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Public Float
EntityPublicFloat
115071927
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
69162223
CY2022 dei Auditor Firm
AuditorFirmId
1263
CY2022 dei Auditor Name
AuditorName
Ernst and Young LLP
CY2022 dei Auditor Location
AuditorLocation
Toronto, Canada
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
17004000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6616000
CY2022Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
1773000
CY2021Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
1592000
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
16871000
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
3558000
CY2022Q4 us-gaap Assets Current
AssetsCurrent
35648000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
11766000
CY2022Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
347793000
CY2021Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
333447000
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
60000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
35000
CY2022Q4 us-gaap Assets
Assets
383501000
CY2021Q4 us-gaap Assets
Assets
345248000
CY2022Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
26358000
CY2021Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
1406000
CY2022Q4 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
8661000
CY2021Q4 us-gaap Long Term Line Of Credit
LongTermLineOfCredit
12620000
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
700000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
700000000
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
69162223
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
69162223
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
117000
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
117000
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
547114000
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
544383000
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-198749000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-213278000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
348482000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
331222000
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
383501000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
345248000
CY2022 us-gaap Exploration Expense
ExplorationExpense
110000
CY2021 us-gaap Exploration Expense
ExplorationExpense
1657000
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
25468000
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
21447000
CY2022 us-gaap Adjustment For Amortization
AdjustmentForAmortization
180000
CY2021 us-gaap Adjustment For Amortization
AdjustmentForAmortization
89000
CY2022 us-gaap Costs And Expenses
CostsAndExpenses
25758000
CY2021 us-gaap Costs And Expenses
CostsAndExpenses
23193000
CY2022 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
45230000
CY2021 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
42804000
CY2021 gato Impairment Of Investment In Affiliates
ImpairmentOfInvestmentInAffiliates
80348000
CY2022 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
-7900000
CY2021 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
195000
CY2022 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
433000
CY2021 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
185000
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4955000
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-4738000
CY2022 gato Nonoperating Income Expense And Interest And Debt Expense
NonoperatingIncomeExpenseAndInterestAndDebtExpense
41852000
CY2021 gato Nonoperating Income Expense And Interest And Debt Expense
NonoperatingIncomeExpenseAndInterestAndDebtExpense
-42662000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
16094000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-65855000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1565000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
14529000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-65855000
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.21
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.03
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.21
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.03
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
69162223
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
63994693
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
69309019
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
63994693
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
261386000
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7694000
CY2021 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
127107000
CY2021 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Restricted Stock Units Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition
1163000
CY2021 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
-273000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-65855000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
331222000
CY2022 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2731000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
14529000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
348482000
CY2022 us-gaap Profit Loss
ProfitLoss
14529000
CY2021 us-gaap Profit Loss
ProfitLoss
-65855000
CY2022 us-gaap Adjustment For Amortization
AdjustmentForAmortization
180000
CY2021 us-gaap Adjustment For Amortization
AdjustmentForAmortization
89000
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
2840000
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
7738000
CY2022 us-gaap Income Loss From Equity Method Investments Net Of Dividends Or Distributions
IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
45230000
CY2021 us-gaap Income Loss From Equity Method Investments Net Of Dividends Or Distributions
IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
42804000
CY2021 gato Impairment Of Investment In Affiliates
ImpairmentOfInvestmentInAffiliates
80348000
CY2022 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-199000
CY2021 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
260000
CY2022 gato Dividends From Affiliates
DividendsFromAffiliates
30775000
CY2022 us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
180000
CY2021 us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
-134000
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
24632000
CY2021 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-1196000
CY2022 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
13191000
CY2021 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-321000
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
14554000
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-21485000
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
60000
CY2021 us-gaap Payments To Acquire Interest In Subsidiaries And Affiliates
PaymentsToAcquireInterestInSubsidiariesAndAffiliates
261439000
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-60000
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-261439000
CY2022 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
-4000000
CY2021 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
13000000
CY2022 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
106000
CY2021 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
7277000
CY2021 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
133085000
CY2021 us-gaap Proceeds From Sale Of Treasury Stock
ProceedsFromSaleOfTreasuryStock
1027000
CY2021 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-441000
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-4106000
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
139394000
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
10388000
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-143530000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6616000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
150146000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
17004000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6616000
CY2022 us-gaap Interest Paid Net
InterestPaidNet
645000
CY2021 us-gaap Interest Paid Net
InterestPaidNet
168000
CY2021 gato Director Fess Converted To Deferred Share Units
DirectorFessConvertedToDeferredShareUnits
306000
CY2022 us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
128000
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 10pt 0pt;">Use of estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The preparation of financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant items subject to such estimates are valuation of stock and stock options; valuation allowances for deferred tax assets; and the fair value of financial instruments and investment in affiliates. At the LGJV, significant items subject to such estimates and assumptions include mineral properties, life of mine revenue and cost assumptions, mineral resource conversion rates to mineral reserves; environmental reclamation and closure obligations and valuation allowances for deferred tax assets.</p>
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
586000
CY2022Q4 us-gaap Value Added Tax Receivable Current
ValueAddedTaxReceivableCurrent
730000
CY2021Q4 us-gaap Value Added Tax Receivable Current
ValueAddedTaxReceivableCurrent
575000
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
2890000
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
2976000
CY2022Q4 us-gaap Insurance Settlements Receivable Current
InsuranceSettlementsReceivableCurrent
13100000
CY2022Q4 gato Deposits And Other Assets Current
DepositsAndOtherAssetsCurrent
151000
CY2021Q4 gato Deposits And Other Assets Current
DepositsAndOtherAssetsCurrent
7000
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
16871000
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
3558000
CY2022Q4 gato Operating Lease Right Of Use Assets
OperatingLeaseRightOfUseAssets
122000
CY2022Q4 gato Operating Lease Liabilities Current
OperatingLeaseLiabilitiesCurrent
112000
CY2022Q4 gato Operating Lease Liabilities Noncurrent
OperatingLeaseLiabilitiesNoncurrent
10000
CY2022 gato Royalty Payment Percentage
RoyaltyPaymentPercentage
0.01
CY2022 gato Mineral Lease And Concession Payments Made
MineralLeaseAndConcessionPaymentsMade
0
CY2021 gato Mineral Lease And Concession Payments Made
MineralLeaseAndConcessionPaymentsMade
24000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
196000
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2761000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
623000
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1889000
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
587000
CY2022Q4 gato Litigation Settlement Liability Current
LitigationSettlementLiabilityCurrent
21000000
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
122000
CY2022Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
26358000
CY2021Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
1406000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
700000000
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
69162223
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
12300000
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
2840000
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
7738000
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
583000
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
833000
CY2022Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
218000
CY2021Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
229000
CY2021Q4 gato Deferred Tax Liabilities Exploration And Development
DeferredTaxLiabilitiesExplorationAndDevelopment
19000
CY2022Q4 us-gaap Deferred Tax Liabilities Prepaid Expenses
DeferredTaxLiabilitiesPrepaidExpenses
551000
CY2022 us-gaap Net Income Loss
NetIncomeLoss
14529000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-65855000
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
69162223
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
63994693
CY2022 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
146796
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
69309019
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
63994693
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.21
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.03
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.21
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.03
CY2022Q4 gato Line Of Credit Facility Decrease In Maximum Borrowing Capacity
LineOfCreditFacilityDecreaseInMaximumBorrowingCapacity
50000000
CY2022Q4 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
50000000
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
16094000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-65855000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1565000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2021Q4 us-gaap Deferred Tax Liabilities Prepaid Expenses
DeferredTaxLiabilitiesPrepaidExpenses
585000
CY2022Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
769000
CY2021Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
833000
CY2022 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
3380000
CY2021 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-13830000
CY2022 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
20000
CY2021 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-136000
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-3410000
CY2021 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
6000000
CY2022 gato Income Tax Reconciliation Withholding Tax
IncomeTaxReconciliationWithholdingTax
-1565000
CY2022 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
927000
CY2021 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
9223000
CY2022 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-323000
CY2021 us-gaap Income Tax Reconciliation Foreign Income Tax Rate Differential
IncomeTaxReconciliationForeignIncomeTaxRateDifferential
-398000
CY2022 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-594000
CY2021 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-859000
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1565000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2022Q4 gato Current Deferred Tax Assets Accrued Compensation
CurrentDeferredTaxAssetsAccruedCompensation
354000
CY2021Q4 gato Current Deferred Tax Assets Accrued Compensation
CurrentDeferredTaxAssetsAccruedCompensation
29000
CY2022Q4 gato Deferred Tax Assets Contingent Liabilities
DeferredTaxAssetsContingentLiabilities
1661000
CY2022Q4 gato Current Deferred Tax Assets Share Based Compensation
CurrentDeferredTaxAssetsShareBasedCompensation
461000
CY2021Q4 gato Current Deferred Tax Assets Share Based Compensation
CurrentDeferredTaxAssetsShareBasedCompensation
427000
CY2022Q4 us-gaap Deferred Tax Assets Equity Method Investments
DeferredTaxAssetsEquityMethodInvestments
12656000
CY2021Q4 us-gaap Deferred Tax Assets Equity Method Investments
DeferredTaxAssetsEquityMethodInvestments
7395000
CY2022Q4 gato Current Deferred Tax Assets Other Accrued Liabilities
CurrentDeferredTaxAssetsOtherAccruedLiabilities
21000
CY2021Q4 gato Current Deferred Tax Assets Other Accrued Liabilities
CurrentDeferredTaxAssetsOtherAccruedLiabilities
22000
CY2022Q4 gato Noncurrent Deferred Tax Assets Mineral Properties
NoncurrentDeferredTaxAssetsMineralProperties
2009000
CY2021Q4 gato Noncurrent Deferred Tax Assets Mineral Properties
NoncurrentDeferredTaxAssetsMineralProperties
2057000
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
10234000
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Domestic
DeferredTaxAssetsOperatingLossCarryforwardsDomestic
22340000
CY2022Q4 gato Noncurrent Deferred Tax Assets Stock Options
NoncurrentDeferredTaxAssetsStockOptions
8917000
CY2021Q4 gato Noncurrent Deferred Tax Assets Stock Options
NoncurrentDeferredTaxAssetsStockOptions
8518000
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
4129000
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards Foreign
DeferredTaxAssetsOperatingLossCarryforwardsForeign
3049000
CY2022Q4 gato Deferred Tax Assets Exploration And Development
DeferredTaxAssetsExplorationAndDevelopment
41000
CY2022Q4 gato Noncurrent Deferred Tax Assets Other
NoncurrentDeferredTaxAssetsOther
24000
CY2021Q4 gato Noncurrent Deferred Tax Assets Other
NoncurrentDeferredTaxAssetsOther
22000
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
39738000
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
43026000
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
769000
CY2022 us-gaap Unrecognized Tax Benefits Income Tax Penalties Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesExpense
0
CY2022Q2 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
20000000

Files In Submission

Name View Source Status
0001104659-23-074920-index-headers.html Edgar Link pending
0001104659-23-074920-index.html Edgar Link pending
0001104659-23-074920.txt Edgar Link pending
0001104659-23-074920-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gato-20221231.xsd Edgar Link pending
gato-20221231x10k.htm Edgar Link pending
gato-20221231x10k003.jpg Edgar Link pending
gato-20221231x10k008.jpg Edgar Link pending
gato-20221231xex10d102.htm Edgar Link pending
gato-20221231xex10d103.htm Edgar Link pending
gato-20221231xex10d104.htm Edgar Link pending
gato-20221231xex10d105.htm Edgar Link pending
gato-20221231xex10d106.htm Edgar Link pending
gato-20221231xex10d106001.jpg Edgar Link pending
gato-20221231xex10d106002.jpg Edgar Link pending
gato-20221231xex10d107.htm Edgar Link pending
gato-20221231xex10d107001.jpg Edgar Link pending
gato-20221231xex10d107002.jpg Edgar Link pending
gato-20221231xex10d121.htm Edgar Link pending
gato-20221231xex10d122.htm Edgar Link pending
gato-20221231xex10d123.htm Edgar Link pending
gato-20221231xex10d42.htm Edgar Link pending
gato-20221231xex10d6.htm Edgar Link pending
gato-20221231xex10d76.htm Edgar Link pending
gato-20221231xex10d76001.jpg Edgar Link pending
gato-20221231xex10d76002.jpg Edgar Link pending
gato-20221231xex21d1.htm Edgar Link pending
gato-20221231xex23d1.htm Edgar Link pending
gato-20221231xex31d1.htm Edgar Link pending
gato-20221231xex31d2.htm Edgar Link pending
gato-20221231xex32d1.htm Edgar Link pending
gato-20221231xex4d4.htm Edgar Link pending
gato-20221231xex4d4001.jpg Edgar Link pending
gato-20221231xex4d4002.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
gato-20221231_lab.xml Edgar Link unprocessable
gato-20221231_cal.xml Edgar Link unprocessable
gato-20221231_pre.xml Edgar Link unprocessable
gato-20221231x10k_htm.xml Edgar Link completed
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
gato-20221231_def.xml Edgar Link unprocessable